Viagra, cialis may help duchenne muscular dystrophy patients

May 7, 2014 by Steven Reinberg, Healthday Reporter
Viagra, cialis may help duchenne muscular dystrophy patients
Small study finds impotence drugs improved blood flow to muscles in boys with the progressive disease.

(HealthDay)—Drugs normally prescribed to treat erectile dysfunction in adult males may help boys who have a muscle disease called Duchenne muscular dystrophy, according to a new study.

In the small study including just 10 boys with the disease, researchers found that the popular drugs Viagra and Cialis improved blood flow to the boys' weakened muscles.

"Boys with Duchenne muscular dystrophy have a blood flow abnormality—delivery of blood and oxygen to their muscles—that does not increase the way it should during mild exercise," said lead researcher Dr. Ronald Victor, the associate director of the Cedars-Sinai Heart Institute in Los Angeles.

Because the blood vessels do not enlarge in a normal way in Duchenne muscular dystrophy, muscles are starved for oxygen, according to Victor. Cialis and Viagra work by enlarging blood vessels, thus increasing blood flow, which is the same way these drugs help men with erectile dysfunction.

The report was published online May 7 in the journal Neurology.

Duchenne muscular dystrophy is a genetic disease that affects boys and young men. It causes a progressive loss of muscle function to the point where those who have the disease end up in a wheelchair. The disorder causes the body to produce little or no dystrophin, a protein needed to make the chemical nitric oxide. Nitric oxide signals blood vessels to relax during exercise, increasing blood flow.

Until recently, boys with Duchenne often didn't live much beyond their teens, according to the Muscular Dystrophy Association. Advances in care have increased survival for many of those with the disease into their 30s. There are even some who have lived into their 40s and 50s.

Current treatments, such as steroids, can slow muscle degeneration and protect heart and lung function, but they don't correct the abnormal blood flow, according to Victor. And, more than a quarter of patients cannot tolerate steroids or their side effects, the researchers noted.

For the new study, Victor's team compared 10 boys with Duchenne muscular dystrophy, aged 8 to 13, who were taking steroids, with 10 healthy boys of the same ages.

All of the boys with muscular dystrophy could still walk, but some also used a wheelchair or a scooter.

The researchers measured the blood flow in all the boys when they were at rest and when they were doing a handgrip exercise. The tests showed that the boys with Duchenne had abnormal blood flow, even though they were taking steroids.

After giving Cialis or Viagra to the boys with Duchenne, the tests were repeated. After two weeks, the boys who received Cialis were given Viagra and those given Viagra were given Cialis, then all were retested.

Victor's group found that both drugs improved blood flow in boys with Duchenne to the point where it was equal to that of healthy boys.

As for side effects, "A few boys in our study had erections after taking these drugs," Victor noted. "The erections were not painful and not dangerous and resolved spontaneously without treatment."

What's not yet clear is if correcting the abnormal blood flow to the muscles will slow the progress of the disease in any way. But Victor hopes a larger trial will answer that question.

"The findings in this small study led to a large clinical trial, which is enrolling now in the U.S. and abroad, to see if 48 weeks of treatment with once-daily Cialis will slow the decline in walking ability in 7- to 14-year-old boys with Duchenne," he said.

"The findings offer some hope, but we need to wait for the results of the large treatment trial to see if daily treatment with Cialis has a clinically meaningful benefit for boys with this form of muscular dystrophy," he added.

Dr. Migvis Monduy, a pediatric neurologist at Miami Children's Hospital, said: "It's exciting to see new treatment options available for Duchenne. It's not like we have any cure or any effective treatment."

Monduy said that these new findings are very preliminary. The researchers showed that blood flow is improved, she said. "But that doesn't translate to slower disease progression. That's what needs to be proved."

The results of this study won't change clinical practice for the time being, Monduy said.

"We are not going to have anybody prescribing this until we see the results of larger studies, and I wouldn't tell anybody to stop their steroids yet," she said. "We have good evidence that steroids slow down disease progression. But we don't know if these drugs [Cialis or Viagra] will improve outcomes for patients."

Explore further: New muscular dystrophy drug's chances for approval improve

More information: To learn more about Duchenne muscular dystrophy, visit the Muscular Dystrophy Association.

Related Stories

New muscular dystrophy drug's chances for approval improve

April 22, 2014
(HealthDay)—A new drug to treat Duchenne muscular dystrophy may be closer to becoming the first approved treatment for the disease.

In new study, common drug reverses common effect of Becker muscular dystrophy

November 28, 2012
Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients ...

Docs: Heart device might be breakthrough for muscular dystrophy

October 17, 2012
(HealthDay)—A man with Duchenne muscular dystrophy who received a device to help his heart's left ventricle pump blood throughout his body could represent a breakthrough in the treatment of the disease, according to his ...

Preclinical muscular dystrophy data shows promise

November 8, 2012
Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.

Regenerating muscle in Duchenne muscular dystrophy: Age matters

April 14, 2014
A team of scientists led by Pier Lorenzo Puri, M.D., associate professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), in collaboration with Fondazione Santa Lucia in Rome, Italy, have published details ...

Discovery one step closer to treatment for Duchenne muscular dystrophy

July 30, 2013
(Medical Xpress)—A University of Alberta researcher has pinpointed a mutation that brings the medical community another step closer to treating those who suffer from a fatal type of muscular dystrophy. 

Recommended for you

Study of nervous system cells can help to understand degenerative diseases

August 18, 2017
The results of a new study show that many of the genes expressed by microglia differ between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

Researchers make surprising discovery about how neurons talk to each other

August 17, 2017
Researchers at the University of Pittsburgh have uncovered the mechanism by which neurons keep up with the demands of repeatedly sending signals to other neurons. The new findings, made in fruit flies and mice, challenge ...

How we recall the past: Neuroscientists discover a brain circuit dedicated to retrieving memories

August 17, 2017
When we have a new experience, the memory of that event is stored in a neural circuit that connects several parts of the hippocampus and other brain structures. Each cluster of neurons may store different aspects of the memory, ...

Researchers show how particular fear memories can be erased

August 17, 2017
Researchers at the University of California, Riverside have devised a method to selectively erase particular fear memories by weakening the connections between the nerve cells (neurons) involved in forming these memories.

Neurons involved in learning, memory preservation less stable, more flexible than once thought

August 17, 2017
The human brain has a region of cells responsible for linking sensory cues to actions and behaviors and cataloging the link as a memory. Cells that form these links have been deemed highly stable and fixed.

Study uncovers specialized mouse neurons that play a unique role in pain

August 17, 2017
Researchers from the National Institutes of Health have identified a class of sensory neurons (nerve cells that electrically send and receive messages between the body and brain) that can be activated by stimuli as precise ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.